Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,647,998 papers from all fields of science
Search
Sign In
Create Free Account
combretastatin A-1
Known as:
Combretastatin A1
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Stilbenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Computational Design and Synthesis of Novel Fluoro-Analogs of Combretastatins A-4 and A-1.
Y. Zong
,
C. Shea
,
Katherine G. Maffucci
,
I. Ojima
Journal of fluorine chemistry
2017
Corpus ID: 206045845
Review
2015
Review
2015
Recent advancement in discovery and development of natural product combretastatin-inspired anticancer agents.
P. Patil
,
A. Patil
,
+5 authors
Shital S. Naphade
Anti-Cancer Agents in Medicinal Chemistry
2015
Corpus ID: 41033845
The natural stilbenoids combretastatin A-4 (CA4) and combretastatin A-1 (CA1) are potent antitubulin agents demonstrating…
Expand
2012
2012
A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation.
M. Stratford
,
L. Folkes
Journal of Pharmaceutical and Biomedical Analysis
2012
Corpus ID: 40486293
2012
2012
Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma by HPLC with mass…
M. Stratford
,
L. Folkes
Journal of chromatography. B, Analytical…
2012
Corpus ID: 25746540
2011
2011
Regioselective synthesis of water-soluble monophosphate derivatives of combretastatin A-1.
R. Tanpure
,
Benson L Nguyen
,
+9 authors
K. Pinney
Journal of Natural Products
2011
Corpus ID: 35025180
The natural products combretastatin A-4 (CA4) and combretastatin A-1 (CA1) are potent cancer vascular disrupting agents and…
Expand
2010
2010
A multicenter, open-label phase Ib/II study to assess the safety and clinical activity of intravenous combretastatin A1 diphosphate (OXi4503) as monotherapy in subjects with primary or secondary…
P. Mainwaring
,
J. Lickliter
,
M. Brown
,
M. Millward
,
D. Chaplin
,
Z. Goldberg
2010
Corpus ID: 78557310
TPS164 Background: Combretastatin A1 diphosphate (CA1P, OXi4503) is a novel vascular disrupting agent (VDA) that is a reversible…
Expand
1997
1997
Effects of novel and conventional anti-cancer agents on human endothelial permeability: influence of tumour secreted factors.
M. Watts
,
M. Woodcock
,
S. Arnold
,
D. Chaplin
Anticancer Research
1997
Corpus ID: 20127683
A number of anti-cancer agents have been implicated in vascular toxicity. The effects have been attributed to direct drug…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE